Analysts at Truist Securities called the mid-stage data a "mixed bag," also flagging gastrointestinal adverse events. However ...

Brainstorm tapped Minaris to manufacture NurOwn for its upcoming Phase 3b clinical trial testing the treatment for ALS.

Nothing is clicking for a Rangers offense that is so bad, it has made its great pitching staff nearly irrelevant. | Opinion ...

It’s been nearly a year since Charlottesville lost one of its most respected pediatricians. At 65, he was diagnosed with a ...

The Everylife Foundation for Rare Diseases is offering a new scholarship for U.S. students from the ALS community facing ...

Corcept's ALS drug dazucorilant improved survival despite missing the main goal; ovarian cancer drug combo met its target in ...

Corcept Therapeutics' dazucorilant failed the primary ALS trial goal but showed improved survival outcomes and a safe profile ...

Corcept Therapeutics has tried to cast its recent phase 2 amyotrophic lateral sclerosis (ALS) failure in a more flattering ...

Despite its growing role in tracking MS activity, serum neurofilament light chain lacks diagnostic specificity, experts say.

ALS cases have been steadily rising in the United States for about the past decade, prompting new reporting requirements in Michigan.

Monday marked the annual Lou Gehrig Day, which took place on June 1-2 this year and raises awareness about ALS (Amyotrophic ...

Experts predict cases will rise by 2030, affecting hundreds of Michigan families battling the fatal condition.